Noteworthy, the presence of active caspase-7 has been found in the brain of TgCRND8 mice, an early-onset AD mouse model where a chronic treatment with the caspase inhibitor, Q-VD-OPh, limited tau pathology [46]. This evidence concerns the gene MAPT and Alzheimer disease.